证券记录 · 已归档季度
ARCT
Arcturus Therapeutics Holdings Inc. · Healthcare · Biotechnology
16被追踪持有人
-1Δ持有人
10.27M持有股份
$189.25M报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.9% ·
股份流向 +7.6% ·
净新建仓位 -6.2%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | +4 | 19.18M | $128.95M | +5 | −1 |
| Q1 2026 | 60 | 0 | 18.54M | $142.94M | +4 | −4 |
| Q4 2025 | 60 | 0 | 18.71M | $114.66M | +3 | −3 |
| Q3 2025 | 16 | -1 | 10.27M | $189.25M | +1 | −2 |
| Q2 2025 | 14 | +1 | 8.29M | $107.85M | +2 | −1 |
| Q1 2025 | 10 | +3 | 4.50M | $47.65M | +3 | — |
| Q4 2024 | 7 | -2 | 3.97M | $67.41M | — | −2 |
| Q3 2024 | 8 | -2 | 3.11M | $72.14M | — | −2 |
| Q2 2024 | 10 | — | 3.78M | $92.06M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 2.56M | -2.9% | $47.27M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 1.89M | +4.2% | $34.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 1.89M | +4.2% | $34.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 1.89M | +4.2% | $34.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 1.87M | +9.2% | $34.51M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 14 | State Street Global Advisors ✦ (被动) | 1.05M | +2.5% | $19.27M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 704.88K | — | $12.99M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 704.88K | — | $12.99M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 704.88K | — | $12.99M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 704.88K | — | $12.99M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 704.88K | — | $12.99M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 704.88K | — | $12.99M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Geode Capital Management ✦ (被动) | 611.82K | +0.9% | $11.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 611.82K | +0.9% | $11.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Arrowstreet Capital ✦ | 552.18K | +1371.4% | $10.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 407.21K | — | $7.50M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Goldman Sachs Group ✦ | 144.73K | — | $2.67M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Goldman Sachs Group ✦ | 144.73K | — | $2.67M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 133.88K | -26.3% | $2.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 133.88K | -26.3% | $2.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 89.22K | +3.3% | $1.64M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | Wellington Management ✦ | 85.48K | -23.6% | $1.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | Wellington Management ✦ | 85.48K | -23.6% | $1.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | Wellington Management ✦ | 85.48K | -23.6% | $1.58M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | D. E. Shaw & Co. ✦ | 60.21K | +476.9% | $1.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | D. E. Shaw & Co. ✦ | 60.21K | +476.9% | $1.11M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 42.12K | +46.9% | $776,272 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | Millennium Management ✦ | 39.80K | 新增 | $733,514 | 0.0% | New | 1 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 27.95K | +20.1% | $516,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $733,514 | 0.0% |
已清仓
| AQR Capital Management | $145,946 | 曾为 0.0% |
| Point72 Asset Management | $80,059 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 124 持有人, 24.09M 股份, $182.18M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据